Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Myo-inositol and Selenium in Patients With Indeterminate Thyroid Nodules (TIR3A)

NCT06736015 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.

NCT NCT06736015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06736015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Myo-inositol and Selenium in Patients With Indeterminate Thyroid Nodules (TIR3A)
Lead sponsor
Regina Elena Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2024
Completion date
September 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid nodule